Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Glaspole

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Immunology and Allergy Clinics of North America|April 13, 2023
Occupational Interstitial Lung DiseasesHayley Barnes, Ian Glaspole
The Lancet. Respiratory Medicine|October 7, 2022
Lockdown as the mother of invention: disruptive technology in a disrupted timeAnne E Holland, Ian Glaspole
Chronic Respiratory Disease|August 7, 2010
Differentiating between IPF and NSIPIan Glaspole, Nicole Soo Leng Goh
Rheumatology (Oxford, England)|April 1, 2014
Comment on: A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis: replyIan Glaspole, Ryan Hoy, Peter Ryan
Respiratory Medicine Case Reports|October 14, 2024
Hermansky-Pudlak Syndrome: An unusual pattern of pulmonary fibrosisMatthew Donnan, Samantha Ellis, Ian Glaspole
Respirology (Carlton, Vic.)|October 4, 2018
Understanding the patient's experience of care in idiopathic pulmonary fibrosisKimberley Burnett, Ian Glaspole, Anne E Holland
Patient Education and Counseling|January 27, 2019
Comprehensive pulmonary rehabilitation for interstitial lung disease: A consensus approach to identify core education topicsAnne E Holland, Alice Watson, Ian Glaspole
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 17, 2021
Inhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosisJade Jaffar, Ian Glaspole, Karen Symons, et al.
Respirology (Carlton, Vic.)|June 2, 2024
Steroid therapy in acute exacerbation of fibrotic interstitial lung diseaseKavya Koshy, Hayley Barnes, Erica Farrand, et al.
Respirology (Carlton, Vic.)|February 22, 2019
Therapeutic burden in interstitial lung disease: Lessons to learnYet H Khor, Ian Glaspole, Nicole S L Goh
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Immunology and Allergy Clinics of North America|April 13, 2023
Occupational Interstitial Lung DiseasesHayley Barnes, Ian Glaspole
The Lancet. Respiratory Medicine|October 7, 2022
Lockdown as the mother of invention: disruptive technology in a disrupted timeAnne E Holland, Ian Glaspole
Chronic Respiratory Disease|August 7, 2010
Differentiating between IPF and NSIPIan Glaspole, Nicole Soo Leng Goh
Rheumatology (Oxford, England)|April 1, 2014
Comment on: A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis: replyIan Glaspole, Ryan Hoy, Peter Ryan
Respiratory Medicine Case Reports|October 14, 2024
Hermansky-Pudlak Syndrome: An unusual pattern of pulmonary fibrosisMatthew Donnan, Samantha Ellis, Ian Glaspole
Respirology (Carlton, Vic.)|October 4, 2018
Understanding the patient's experience of care in idiopathic pulmonary fibrosisKimberley Burnett, Ian Glaspole, Anne E Holland
Patient Education and Counseling|January 27, 2019
Comprehensive pulmonary rehabilitation for interstitial lung disease: A consensus approach to identify core education topicsAnne E Holland, Alice Watson, Ian Glaspole
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 17, 2021
Inhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosisJade Jaffar, Ian Glaspole, Karen Symons, et al.
Respirology (Carlton, Vic.)|June 2, 2024
Steroid therapy in acute exacerbation of fibrotic interstitial lung diseaseKavya Koshy, Hayley Barnes, Erica Farrand, et al.
Respirology (Carlton, Vic.)|February 22, 2019
Therapeutic burden in interstitial lung disease: Lessons to learnYet H Khor, Ian Glaspole, Nicole S L Goh
Pageof 10